PT812206E - Proteina de ligacao a cd40 para estimulacao de uma resposta imunitaria - Google Patents

Proteina de ligacao a cd40 para estimulacao de uma resposta imunitaria

Info

Publication number
PT812206E
PT812206E PT96909555T PT96909555T PT812206E PT 812206 E PT812206 E PT 812206E PT 96909555 T PT96909555 T PT 96909555T PT 96909555 T PT96909555 T PT 96909555T PT 812206 E PT812206 E PT 812206E
Authority
PT
Portugal
Prior art keywords
immune response
protein
ligacao
stimulation
individuals
Prior art date
Application number
PT96909555T
Other languages
English (en)
Inventor
Mark Alderson
Kim A Campbell
Mary K Kennedy
Charles R Maliszewski
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of PT812206E publication Critical patent/PT812206E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
PT96909555T 1995-03-01 1996-02-29 Proteina de ligacao a cd40 para estimulacao de uma resposta imunitaria PT812206E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39623095A 1995-03-01 1995-03-01

Publications (1)

Publication Number Publication Date
PT812206E true PT812206E (pt) 2002-11-29

Family

ID=23566398

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96909555T PT812206E (pt) 1995-03-01 1996-02-29 Proteina de ligacao a cd40 para estimulacao de uma resposta imunitaria

Country Status (15)

Country Link
EP (1) EP0812206B1 (pt)
JP (1) JP3657271B2 (pt)
KR (1) KR19980702490A (pt)
AT (1) ATE220331T1 (pt)
AU (1) AU699291B2 (pt)
CA (1) CA2213798C (pt)
DE (1) DE69622259T2 (pt)
DK (1) DK0812206T3 (pt)
ES (1) ES2179187T3 (pt)
FI (1) FI973484A (pt)
MX (1) MX9706588A (pt)
NO (1) NO973875L (pt)
NZ (1) NZ305083A (pt)
PT (1) PT812206E (pt)
WO (1) WO1996026735A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033406A4 (en) * 1997-10-27 2005-03-09 Sumitomo Electric Industries INDUCER FOR THE PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODY, EXPRESSION VECTOR CONTAINING THE GENE REQUIRED THEREFOR, AND METHOD FOR INDUCING THE PRODUCTION OF THE ANTIGEN-SPECIFIC ANTIBODY
EP1059932A1 (en) * 1997-12-19 2000-12-20 Immunex Corporation Method for reducing susceptibility to hiv infection
EP1082141B1 (en) * 1998-05-23 2005-09-14 Leiden university medical center Cd40 binding antibodies and ctl peptides for treating tumors
CA2399790C (en) 2000-02-02 2012-10-30 Ralph A. Tripp Cd40 ligand adjuvant for respiratory syncytial virus
EP2517723B1 (en) 2006-09-18 2019-11-06 The Board of Trustees of The University of Arkansas Compositions and methods of enhancing immune responses
BRPI0818736A2 (pt) 2007-10-30 2017-06-13 Univ Arkansas composições e métodos para intensificar imunorrepostas à bactéria flagelada
HUE047164T2 (hu) 2007-11-01 2020-04-28 Univ Arkansas Kompozíciók és eljárások eimeria elleni immunválasz fokozására
EP2525817B8 (en) 2010-01-21 2017-09-20 The Board of Trustees of The University of Arkansas Vaccine vectors and methods of enhancing immune responses
HUE046858T2 (hu) 2010-06-09 2020-03-30 Univ Arkansas Vakcina és eljárások campylobacter fertõzés csökkentésére
MX339239B (es) 2011-04-29 2016-05-18 Apexigen Inc Anticuerpos anti-cd40 y metodos de uso.
CN104918957B (zh) 2012-10-30 2018-11-16 埃派斯进有限公司 抗-cd40抗体及其使用方法
MY173328A (en) 2013-02-14 2020-01-16 Texas A & M Univ Sys Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
EA033538B1 (ru) 2013-03-15 2019-10-31 Univ Arkansas Композиции и способы усиления иммунного ответа на кишечные патогены
JP2018521983A (ja) 2015-07-16 2018-08-09 バイオカイン セラピューティックス リミテッド がんを治療するための組成物および方法
JP7038064B2 (ja) 2016-04-18 2022-03-17 セルデックス セラピューティクス インコーポレイテッド ヒトｃｄ４０に結合するアゴニスト抗体およびその使用
TWI758288B (zh) 2016-05-03 2022-03-21 阿肯色州大學董事會 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3308534B2 (ja) * 1991-10-25 2002-07-29 イミュネックス・コーポレーション 新規なサイトカイン
AU5098493A (en) * 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
ES2211884T3 (es) * 1993-10-01 2004-07-16 Immunex Corporation Anticuerpos contra el cd40.

Also Published As

Publication number Publication date
EP0812206B1 (en) 2002-07-10
ATE220331T1 (de) 2002-07-15
AU699291B2 (en) 1998-11-26
NO973875L (no) 1997-10-31
ES2179187T3 (es) 2003-01-16
JPH11506418A (ja) 1999-06-08
DE69622259T2 (de) 2003-03-27
NO973875D0 (no) 1997-08-22
MX9706588A (es) 1997-11-29
DK0812206T3 (da) 2002-09-09
JP3657271B2 (ja) 2005-06-08
DE69622259D1 (de) 2002-08-14
FI973484A0 (fi) 1997-08-25
KR19980702490A (ko) 1998-07-15
CA2213798C (en) 2001-02-06
FI973484A (fi) 1997-10-24
EP0812206A1 (en) 1997-12-17
AU5301196A (en) 1996-09-18
NZ305083A (en) 1999-06-29
CA2213798A1 (en) 1996-09-06
WO1996026735A1 (en) 1996-09-06

Similar Documents

Publication Publication Date Title
PT812206E (pt) Proteina de ligacao a cd40 para estimulacao de uma resposta imunitaria
DK0724456T3 (da) CD40-Antistoffer
DE69316948D1 (de) Lösliche Liganden für CD40
FI963004A0 (fi) Vasta-aineen muodostumista kiihottavia monoklonaalivasta-aineita
DE69129989D1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
DE69738692D1 (de) LO-CD2a ANTIKÖRPER UND DESSEN VERWENDUNGEN ZUR HEM
NO971059D0 (no) Modifiserte human-C3-proteiner
DE50114906D1 (de) Verwendung cd28 spezifischer monoklonaler antikörper zur stimulation von blutzellen, welche kein cd28 tragen
DE60109359D1 (de) Verwendung von anti-ferritin antikörper bei der behandlung von bestimmten krebsarten
ATE309371T1 (de) Protein mit dnase-aktivität